Bayer Sees Growth in Life Sciences, Agrochemicals

March 14, 2012
Predicting sales of $26 billion in healthcare division in 2014

Bayer is positive about the coming years. "We see good perspectives for our businesses in the medium term. In our so-called life science areas -- healthcare and crop science -- we anticipate further increases in sales and margins through 2014," said chief executive Marijn Dekkers.

At Bayer's healthcare division, sales were expected to reach "approximately 20 billion euros (US$26 billion) in 2014" from 17.169 billion euros last year.

The crop science division would raise sales to "more than 8.0 billion euros (US$10.5 billion)" in 2014 from 7.255 billion euros in 2011.

"The main reason why I'm optimistic for our healthcare subgroup is our well-stocked development pipeline in pharmaceuticals," Dekkers told an investor conference.

"We believe four of our medicines in late-stage development have blockbuster potential. That means each of these products could achieve peak annual sales of 1.0 billion or more." The four products are the anti-coagulant Xarelto, the eye medicine VEGF Trap-Eye, and the cancer drugs Alpharadin and regorafenib.

"We believe Xarelto alone to have a peak sales potential of more than 2.0 billion euros," Dekkers said.

As reported last month, Bayer lifted net profit by 90% to 2.47 billion euros (US$3.2 bilion) in 2011 on a 4.1% increase in sales to 36.528 billion euros.

Copyright Agence France-Presse, 2012

Popular Sponsored Recommendations

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Four Keys To Operational Excellence

Sept. 20, 2023
As manufacturers face supply chain disruption and shrinking margins, increasing operations performance is critical. Our smart manufacturing guidebook can help you achieve the ...

Gain a competitive edge with real-world lessons on private 5G networks

Nov. 16, 2023
The use of private networks in manufacturing applications is rapidly growing. In this paper, we present valuable insights and lessons learned from the field with the goal of enhancing...

Navigating Disruption: A Leader’s Guide to Strategy Under Uncertainty

Nov. 1, 2023
AI, sustainability, digital--industrials are facing disruptive forces that are redefining what it takes to win. What got your company where it is today won’t get you where you...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!